Clinical Trial Update: LIPIDS-P Trial Phase I/II Trial [Phase 1, Phase 2]

View source ↗

Summary

The LIPIDS-P trial, a Phase I/II study, has completed and posted results evaluating its safety and preliminary efficacy in sepsis and septic shock.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• LIPIDS-P

Snippet

Sponsor: University of Florida | Conditions: Sepsis, Severe, Septic Shock | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-08-11